+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Oral Clinical Nutrition Market Size, Share & Trends Analysis Report by Stage (Adults, Pediatrics), Indication (Dysphagia, Alzheimer's, Diabetes), Sales Channel (Online Sales, Retail Sales), and Region with Growth Forecasts, 2025-2030

  • PDF Icon

    Report

  • 100 Pages
  • May 2025
  • Region: Global
  • Grand View Research
  • ID: 5748318
The Oral Clinical Nutrition Market was valued at USD 17.16 billion in 2024, and is projected to reach USD 22.97 billion by 2030, rising at a CAGR of 5.00%., Oral clinical nutrition are the supplements such electrolytes, protein, fibre, energy, vitamins and minerals essential for the people with nutrient deficiency. This is due to poor appetite, low food intake and illness. These nutritional products are available in the form of powder, liquid, pudding, fiber, dessert, juices, yogurt and so on which can be consumed orally. They also have a wide range of applications in the treatment of chronic diseases such as cancer, neurological conditions and gastrointestinal disorders.

The key market players are involved in the novel product launch contributing to the global market growth. For instance, in April 2018, Abbott launched a beverage Ensure Protein Max with 2 for people over age 50+ having protein deficiency. The beverage contains 30g protein with 150 calories and 9 amino acids and available in two flavors. The beverage is supplemented with 1g sugar and 22 vitamins and minerals such as Vitamin D, C, and E. Such novel product launch by market players is expected to propel market growth.

Dominant market players are also engaged in collaborations, mergers, acquisitions to enhance the product portfolio and improvise the nutrition portfolio of the company and study the clinical nutrition analysis. This has a positive impact on the global market. For instance, in January 2018, Filament BioSolutions, Inc. entered into a strategic collaboration with CHEO, Ottawa and Ottawa University for a project designed to analyze and study the clinical application of microme-based precision nutrition in IBD. The project was funded by CIHR and Genome Canada.

Moreover, there is rising awareness among people regarding a healthy lifestyle, and consumption of a nutritious diet for improving the body's immunity and living a healthy and fit life. Along with this, there is a rising prevalence of chronic diseases such as cancer. According to the research, loss of appetite, and malnutrition is observed due to the side effects of the clinical treatment. Due to this, the researchers are engaged in formulating oral clinical nutrition supplements by enhancing their nutritional value to counter the side effects of the clinical treatment. This helps in the overall growth of the market. The government and private organizations are investing and raising funds to cater to the problems of malnutrition by improving the R&D and healthcare sector. For instance, in September 2022, Biden-Harris Administration held a White House Conference on Hunger, Nutrition and Health in America to solve the issues of food and proper diet related to nutrient deficiency due to diseases such as diabetes, hypertension, and obesity. The conference stated that over USD 4 billion will be invested by the government in the food nutrition industry to improve the nutritional content in the food and promote a healthy living. Such initiative has led to the development of more advanced and effective oral clinical nutrition supplements, which has increased their adoption and growth in the market.

Further, the COVID-19 pandemic has had a positive impact on the oral clinical nutrition market. The demand for oral clinical nutrition supplements has increased catering to the issues faced due to malnutrition. In order to improve the body's immunity, people have started consuming nutritious food, and supplements enriched with vitamins, fibers, and proteins. Moreover, these supplements are easy to consume. Thus, the global sale of these products has increased in recent years. Market players have also started enhancing the manufacturing capabilities of the food and nutrition departments to cater to the growing demand for quality and regulatory-certified food supplements.

Oral Clinical Nutrition Market Report Highlights

  • In 2024, the adult segment held a majority share of the market owing to the increasing incidence of chronic diseases as well as growing awareness about the advantages of clinical nutrition consumed orally to improve health conditions and nutrient deficiency.
  • Cancer care segment held the largest share in 2024, owing to its rising prevalence and hospital admissions for cancer treatment.
  • Institutional sales held the largest share in 2024. The rise in hospital admissions and a growing number of healthcare facilities such as long-term care centers globally is further driving the segment growth.
  • North America held the largest share in 2024, owing to factors such as a large geriatric population, chronic disease burden, and high public & private expenditures on healthcare.

This report addresses:

  • Market intelligence to enable effective decision-making
  • Market estimates and forecasts from 2018 to 2030
  • Growth opportunities and trend analyses
  • Segment and regional revenue forecasts for market assessment
  • Competition strategy and market share analysis
  • Product innovation listings for you to stay ahead of the curve

Why Should You Buy This Report?

  • Comprehensive Market Analysis: Gain detailed insights into the market across major regions and segments.
  • Competitive Landscape: Explore the market presence of key players.
  • Future Trends: Discover the pivotal trends and drivers shaping the future of the market.
  • Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.

This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Stage
1.2.2. Indication
1.2.3. Sales Channel
1.2.4. Regional scope
1.2.5. Estimates and forecasts timeline
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.4.5. Details of primary research
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.2. Approach 1: Commodity flow approach
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Stage outlook
2.2.2. Indication outlook
2.2.3. Sales Channel outlook
2.2.4. Regional outlook
2.3. Competitive Insights
Chapter 3. Oral Clinical Nutrition Market Variables, Trends & Scope
3.1. Pricing Analysis
3.2. Industry Analysis
3.2.1. User perspective analysis
3.2.2. Key end users
3.3. Technology Outlook
3.4. Regulatory Framework
3.5. Market Lineage Outlook
3.5.1. Parent market outlook
3.6. Market Dynamics
3.6.1. Market driver analysis
3.6.1.1. Rising geriatric population
3.6.1.2. Growing prevalence of chronic diseases
3.6.1.3. Increasing incidence of Cancer
3.6.1.4. Increasing risk of malnutrition
3.6.1.5. Shifting trend toward the consumption of disease-specific formulas
3.6.1.6. Growing demand for neonatal and preterm enteral feeding
3.6.1.7. Rising organizational strategic initiatives To enhance market presence
3.6.2. Market restraint analysis
3.6.2.1. Lack of awareness in the medical community
3.6.2.2. Improper categorization of clinical nutrition
3.6.3. Market opportunity analysis
3.6.4. Market challenges analysis
3.7. Oral Clinical Nutrition Market Analysis Tools
3.7.1. Industry Analysis - Porter’s Five Forces
3.7.1.1. Supplier power
3.7.1.2. Buyer power
3.7.1.3. Substitution threat
3.7.1.4. Threat of new entrant
3.7.1.5. Competitive rivalry
3.7.2. PESTEL Analysis
3.7.2.1. Political landscape
3.7.2.2. Economic and Social landscape
3.7.2.3. Technological landscape
3.7.2.4. Environmental landscape
3.7.2.5. Legal Landscape
3.8. Pricing Analysis
3.9. COVID-19 Impact
Chapter 4. Oral Clinical Nutrition Market: Stage Estimates & Trend Analysis
4.1. Global Oral Clinical Nutrition Market: Stage Dashboard
4.2. Stage Market Share Analysis, 2024 & 2030
4.3. Oral Clinical Nutrition Market: By Stage, 2018 to 2030
4.4. Adults
4.4.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
4.5. Pediatrics
4.5.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 5. Oral Clinical Nutrition Market: Indication Estimates & Trend Analysis
5.1. Global Oral Clinical Nutrition Market: Indication Dashboard
5.2. Indication Market Share Analysis, 2024 & 2030
5.3. Oral Clinical Nutrition Market: By Indication, 2018 to 2030
5.4. Alzheimer’s
5.4.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
5.5. Nutrition Deficiency
5.5.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
5.6. Cancer Care
5.6.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
5.7. Diabetes
5.7.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
5.8. Chronic Kidney Diseases
5.8.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
5.9. Orphan Diseases
5.9.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
5.10. Dysphagia
5.10.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
5.11. Pain Management
5.11.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
5.12. Malabsorption/GI Disorder/Diarrhea
5.12.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
5.13. Others
5.13.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 6. Oral Clinical Nutrition Market: Sales Channel Estimates & Trend Analysis
6.1. Global Oral Clinical Nutrition Market: Sales Channel Dashboard
6.2. Sales Channel Market Share Analysis, 2024 & 2030
6.3. Oral Clinical Nutrition Market: By Sales Channel, 2018 to 2030
6.4. Online Sales
6.4.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
6.5. Retail Sales
6.5.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
6.6. Institutional Sales
6.6.1. Market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 7. Oral Clinical Nutrition Market: Regional Estimates & Trend Analysis by stage, indication and sales channel
7.1. Regional Dashboard
7.2. Market Size & Forecasts Trend Analysis, 2018 to 2030
7.3. North America
7.3.1. U.S.
7.3.1.1. Key country dynamics
7.3.1.2. Regulatory framework/Reimbursement Scenario/Reimbursement Scenario
7.3.1.3. Competitive scenario
7.3.1.4. U.S. market estimates and forecasts, 2018 to 2030 (USD Million)
7.3.2. Canada
7.3.2.1. Key country dynamics
7.3.2.2. Regulatory framework/Reimbursement Scenario
7.3.2.3. Competitive scenario
7.3.2.4. Canada market estimates and forecasts, 2018 to 2030 (USD Million)
7.3.3. Mexico
7.3.3.1. Key country dynamics
7.3.3.2. Regulatory framework/Reimbursement Scenario
7.3.3.3. Competitive scenario
7.3.3.4. Mexico market estimates and forecasts, 2018 to 2030 (USD Million)
7.4. Europe
7.4.1. UK
7.4.1.1. Key country dynamics
7.4.1.2. Regulatory framework/Reimbursement Scenario
7.4.1.3. Competitive scenario
7.4.1.4. UK market estimates and forecasts, 2018 to 2030 (USD Million)
7.4.2. Germany
7.4.2.1. Key country dynamics
7.4.2.2. Regulatory framework/Reimbursement Scenario
7.4.2.3. Competitive scenario
7.4.2.4. Germany market estimates and forecasts, 2018 to 2030 (USD Million)
7.4.3. France
7.4.3.1. Key country dynamics
7.4.3.2. Regulatory framework/Reimbursement Scenario
7.4.3.3. Competitive scenario
7.4.3.4. France market estimates and forecasts, 2018 to 2030 (USD Million)
7.4.4. Italy
7.4.4.1. Key country dynamics
7.4.4.2. Regulatory framework/Reimbursement Scenario
7.4.4.3. Competitive scenario
7.4.4.4. Italy market estimates and forecasts, 2018 to 2030 (USD Million)
7.4.5. Spain
7.4.5.1. Key country dynamics
7.4.5.2. Regulatory framework/Reimbursement Scenario
7.4.5.3. Competitive scenario
7.4.5.4. Spain market estimates and forecasts, 2018 to 2030 (USD Million)
7.4.6. Denmark
7.4.6.1. Key country dynamics
7.4.6.2. Regulatory framework/Reimbursement Scenario
7.4.6.3. Competitive scenario
7.4.6.4. Denmark market estimates and forecasts, 2018 to 2030 (USD Million)
7.4.7. Sweden
7.4.7.1. Key country dynamics
7.4.7.2. Regulatory framework/Reimbursement Scenario
7.4.7.3. Competitive scenario
7.4.7.4. Sweden market estimates and forecasts, 2018 to 2030 (USD Million)
7.4.8. Norway
7.4.8.1. Key country dynamics
7.4.8.2. Regulatory framework/Reimbursement Scenario
7.4.8.3. Competitive scenario
7.4.8.4. Norway market estimates and forecasts, 2018 to 2030 (USD Million)
7.5. Asia Pacific
7.5.1. Japan
7.5.1.1. Key country dynamics
7.5.1.2. Regulatory framework/Reimbursement Scenario
7.5.1.3. Competitive scenario
7.5.1.4. Japan market estimates and forecasts, 2018 to 2030 (USD Million)
7.5.2. China
7.5.2.1. Key country dynamics
7.5.2.2. Regulatory framework/Reimbursement Scenario
7.5.2.3. Competitive scenario
7.5.2.4. China market estimates and forecasts, 2018 to 2030 (USD Million)
7.5.3. India
7.5.3.1. Key country dynamics
7.5.3.2. Regulatory framework/Reimbursement Scenario
7.5.3.3. Competitive scenario
7.5.3.4. India market estimates and forecasts, 2018 to 2030 (USD Million)
7.5.4. South Korea
7.5.4.1. Key country dynamics
7.5.4.2. Regulatory framework/Reimbursement Scenario
7.5.4.3. Competitive scenario
7.5.4.4. South Korea market estimates and forecasts, 2018 to 2030 (USD Million)
7.5.5. Thailand
7.5.5.1. Key country dynamics
7.5.5.2. Regulatory framework/Reimbursement Scenario
7.5.5.3. Competitive scenario
7.5.5.4. Thailand market estimates and forecasts, 2018 to 2030 (USD Million)
7.5.6. Australia
7.5.6.1. Key country dynamics
7.5.6.2. Regulatory framework/Reimbursement Scenario
7.5.6.3. Competitive scenario
7.5.6.4. Australia market estimates and forecasts, 2018 to 2030 (USD Million)
7.6. Latin America
7.6.1. Brazil
7.6.1.1. Key country dynamics
7.6.1.2. Regulatory framework/Reimbursement Scenario
7.6.1.3. Competitive scenario
7.6.1.4. Brazil market estimates and forecasts, 2018 to 2030 (USD Million)
7.6.2. Argentina
7.6.2.1. Key country dynamics
7.6.2.2. Regulatory framework/Reimbursement Scenario
7.6.2.3. Competitive scenario
7.6.2.4. Argentina market estimates and forecasts, 2018 to 2030 (USD Million)
7.7. MEA
7.7.1. South Africa
7.7.1.1. Key country dynamics
7.7.1.2. Regulatory framework/Reimbursement Scenario
7.7.1.3. Competitive scenario
7.7.1.4. South Africa market estimates and forecasts, 2018 to 2030 (USD Million)
7.7.2. Saudi Arabia
7.7.2.1. Key country dynamics
7.7.2.2. Regulatory framework/Reimbursement Scenario
7.7.2.3. Competitive scenario
7.7.2.4. Saudi Arabia market estimates and forecasts, 2018 to 2030 (USD Million)
7.7.3. UAE
7.7.3.1. Key country dynamics
7.7.3.2. Regulatory framework/Reimbursement Scenario
7.7.3.3. Competitive scenario
7.7.3.4. UAE market estimates and forecasts, 2018 to 2030 (USD Million)
7.7.4. Kuwait
7.7.4.1. Key country dynamics
7.7.4.2. Regulatory framework/Reimbursement Scenario
7.7.4.3. Competitive scenario
7.7.4.4. Kuwait market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 8. Competitive Landscape
8.1. Company Market Share Analysis, 2024
8.2. Company Heat Map Analysis
8.3. Company/Competition Categorization
8.4. Company Profiles
8.4.1. Fresenius Kabi AG
8.4.1.1. Overview
8.4.1.2. Financial performance
8.4.1.3. Product benchmarking
8.4.1.4. Strategic initiatives
8.4.2. Abbott Laboratories
8.4.2.1. Overview
8.4.2.2. Financial performance
8.4.2.3. Product benchmarking
8.4.2.4. Strategic initiatives
8.4.3. Pfizer Inc.
8.4.3.1. Overview
8.4.3.2. Financial performance
8.4.3.3. Product benchmarking
8.4.3.4. Strategic initiatives
8.4.4. Bayer AG
8.4.4.1. Overview
8.4.4.2. Financial performance
8.4.4.3. Product benchmarking
8.4.4.4. Strategic initiatives
8.4.5. Nestle S.A.
8.4.5.1. Overview
8.4.5.2. Financial performance
8.4.5.3. Product benchmarking
8.4.5.4. Strategic initiatives
8.4.6. GlaxoSmithKline plc
8.4.6.1. Overview
8.4.6.2. Financial performance
8.4.6.3. Product benchmarking
8.4.6.4. Strategic initiatives
8.4.7. Baxter International Inc.
8.4.7.1. Overview
8.4.7.2. Financial performance
8.4.7.3. Product benchmarking
8.4.7.4. Strategic initiatives
8.4.8. Otsuka Holdings Co., Ltd.
8.4.8.1. Overview
8.4.8.2. Financial performance
8.4.8.3. Product benchmarking
8.4.8.4. Strategic initiatives
8.4.9. Mead Johnson & Company, LLC
8.4.9.1. Overview
8.4.9.2. Financial performance
8.4.9.3. Product benchmarking
8.4.9.4. Strategic initiatives
8.4.10. Danone (Nutricia)
8.4.10.1. Overview
8.4.10.2. Financial performance
8.4.10.3. Product benchmarking
8.4.10.4. Strategic initiatives
8.4.11. B. Braun Melsungen AG.
8.4.11.1. Overview
8.4.11.2. Financial performance
8.4.11.3. Product benchmarking
8.4.11.4. Strategic initiatives
8.4.12. Kate Farms, Inc.
8.4.12.1. Overview
8.4.12.2. Financial performance
8.4.12.3. Product benchmarking
8.4.12.4. Strategic initiatives
8.4.13. Medline Industries, LP
8.4.13.1. Overview
8.4.13.2. Financial performance
8.4.13.3. Product benchmarking
8.4.13.4. Strategic initiatives
List of Tables
Table 1 List of secondary sources
Table 2 List of abbreviations
Table 3 North America oral clinical nutrition market estimates and forecasts, by stage, 2018-2030 (USD Million)
Table 4 North America oral clinical nutrition market estimates and forecasts, by indication, 2018-2030 (USD Million)
Table 5 North America oral clinical nutrition market estimates and forecasts by sales channel, 2018-2030 (USD Million)
Table 6 U.S oral clinical nutrition market estimates and forecasts, by stage, 2018-2030 (USD Million)
Table 7 U.S oral clinical nutrition market estimates and forecasts, by indication, 2018-2030 (USD Million)
Table 8 U.S oral clinical nutrition market estimates and forecasts by sales channel, 2018-2030 (USD Million)
Table 9 Canada oral clinical nutrition market estimates and forecasts, by stage, 2018-2030 (USD Million)
Table 10 Canada oral clinical nutrition market estimates and forecasts, by indication, 2018-2030 (USD Million)
Table 11 Canada oral clinical nutrition market estimates and forecasts by sales channel, 2018-2030 (USD Million)
Table 12 Mexico oral clinical nutrition market estimates and forecasts, by stage, 2018-2030 (USD Million)
Table 13 Mexico oral clinical nutrition market estimates and forecasts, by indication, 2018-2030 (USD Million)
Table 14 Mexico oral clinical nutrition market estimates and forecasts by sales channel, 2018-2030 (USD Million)
Table 15 Europe oral clinical nutrition market estimates and forecasts, by stage, 2018-2030 (USD Million)
Table 16 Europe oral clinical nutrition market estimates and forecasts, by indication, 2018-2030 (USD Million)
Table 17 Europe oral clinical nutrition market estimates and forecasts by sales channel, 2018-2030 (USD Million)
Table 18 UK oral clinical nutrition market estimates and forecasts, by stage, 2018-2030 (USD Million)
Table 19 UK oral clinical nutrition market estimates and forecasts, by indication, 2018-2030 (USD Million)
Table 20 UK oral clinical nutrition market estimates and forecasts by sales channel, 2018-2030 (USD Million)
Table 21 Germany oral clinical nutrition market estimates and forecasts, by stage, 2018-2030 (USD Million)
Table 22 Germany oral clinical nutrition market estimates and forecasts, by indication, 2018-2030 (USD Million)
Table 23 Germany oral clinical nutrition market estimates and forecasts by sales channel, 2018-2030 (USD Million)
Table 24 France oral clinical nutrition market estimates and forecasts, by stage, 2018-2030 (USD Million)
Table 25 France oral clinical nutrition market estimates and forecasts, by indication, 2018-2030 (USD Million)
Table 26 France oral clinical nutrition market estimates and forecasts by sales channel, 2018-2030 (USD Million)
Table 27 Italy oral clinical nutrition market estimates and forecasts, by stage, 2018-2030 (USD Million)
Table 28 Italy oral clinical nutrition market estimates and forecasts, by indication, 2018-2030 (USD Million)
Table 29 Italy oral clinical nutrition market estimates and forecasts by sales channel, 2018-2030 (USD Million)
Table 30 Spain oral clinical nutrition market estimates and forecasts, by stage, 2018-2030 (USD Million)
Table 31 Spain oral clinical nutrition market estimates and forecasts, by indication, 2018-2030 (USD Million)
Table 32 Spain oral clinical nutrition market estimates and forecasts by sales channel, 2018-2030 (USD Million)
Table 33 Sweden oral clinical nutrition market estimates and forecasts, by stage, 2018-2030 (USD Million)
Table 34 Sweden oral clinical nutrition market estimates and forecasts, by indication, 2018-2030 (USD Million)
Table 35 Sweden oral clinical nutrition market estimates and forecasts by sales channel, 2018-2030 (USD Million)
Table 36 Denmark oral clinical nutrition market estimates and forecasts, by stage, 2018-2030 (USD Million)
Table 37 Denmark oral clinical nutrition market estimates and forecasts, by indication, 2018-2030 (USD Million)
Table 38 Denmark oral clinical nutrition market estimates and forecasts by sales channel, 2018-2030 (USD Million)
Table 39 Norway oral clinical nutrition market estimates and forecasts, by stage, 2018-2030 (USD Million)
Table 40 Norway oral clinical nutrition market estimates and forecasts, by indication, 2018-2030 (USD Million)
Table 41 Norway oral clinical nutrition market estimates and forecasts by sales channel, 2018-2030 (USD Million)
Table 42 Asia Pacific oral clinical nutrition market estimates and forecasts, by stage, 2018-2030 (USD Million)
Table 43 Asia Pacific oral clinical nutrition market estimates and forecasts, by indication, 2018-2030 (USD Million)
Table 44 Asia Pacific oral clinical nutrition market estimates and forecasts by sales channel, 2018-2030 (USD Million)
Table 45 Japan oral clinical nutrition market estimates and forecasts, by stage, 2018-2030 (USD Million)
Table 46 Japan oral clinical nutrition market estimates and forecasts, by indication, 2018-2030 (USD Million)
Table 47 Japan oral clinical nutrition market estimates and forecasts by sales channel, 2018-2030 (USD Million)
Table 48 China oral clinical nutrition market estimates and forecasts, by stage, 2018-2030 (USD Million)
Table 49 China oral clinical nutrition market estimates and forecasts, by indication, 2018-2030 (USD Million)
Table 50 China oral clinical nutrition market estimates and forecasts by sales channel, 2018-2030 (USD Million)
Table 51 India oral clinical nutrition market estimates and forecasts, by stage, 2018-2030 (USD Million)
Table 52 India oral clinical nutrition market estimates and forecasts, by indication, 2018-2030 (USD Million)
Table 53 India oral clinical nutrition market estimates and forecasts by sales channel, 2018-2030 (USD Million)
Table 54 Australia oral clinical nutrition market estimates and forecasts, by stage, 2018-2030 (USD Million)
Table 55 Australia oral clinical nutrition market estimates and forecasts, by indication, 2018-2030 (USD Million)
Table 56 Australia oral clinical nutrition market estimates and forecasts by sales channel, 2018-2030 (USD Million)
Table 57 South Korea oral clinical nutrition market estimates and forecasts, by stage, 2018-2030 (USD Million)
Table 58 South Korea oral clinical nutrition market estimates and forecasts, by indication, 2018-2030 (USD Million)
Table 59 Thailand oral clinical nutrition market estimates and forecasts, by stage, 2018-2030 (USD Million)
Table 60 Thailand oral clinical nutrition market estimates and forecasts, by indication, 2018-2030 (USD Million)
Table 61 Thailand oral clinical nutrition market estimates and forecasts by sales channel, 2018-2030 (USD Million)
Table 62 Latin America oral clinical nutrition market estimates and forecasts, by stage, 2018-2030 (USD Million)
Table 63 Latin America oral clinical nutrition market estimates and forecasts, by indication, 2018-2030 (USD Million)
Table 64 Latin America oral clinical nutrition market estimates and forecasts by sales channel, 2018-2030 (USD Million)
Table 65 Brazil oral clinical nutrition market estimates and forecasts, by stage, 2018-2030 (USD Million)
Table 66 Brazil oral clinical nutrition market estimates and forecasts, by indication, 2018-2030 (USD Million)
Table 67 Brazil oral clinical nutrition market estimates and forecasts by sales channel, 2018-2030 (USD Million)
Table 68 Argentina oral clinical nutrition market estimates and forecasts, by stage, 2018-2030 (USD Million)
Table 69 Argentina oral clinical nutrition market estimates and forecasts, by indication, 2018-2030 (USD Million)
Table 70 Argentina oral clinical nutrition market estimates and forecasts by sales channel, 2018-2030 (USD Million)
Table 71 MEA oral clinical nutrition market estimates and forecasts, by stage, 2018-2030 (USD Million)
Table 72 MEA oral clinical nutrition market estimates and forecasts, by indication, 2018-2030 (USD Million)
Table 73 MEA oral clinical nutrition market estimates and forecasts by sales channel, 2018-2030 (USD Million)
Table 74 South Africa oral clinical nutrition market estimates and forecasts, by stage, 2018-2030 (USD Million)
Table 75 South Africa oral clinical nutrition market estimates and forecasts, by indication, 2018-2030 (USD Million)
Table 76 South Africa oral clinical nutrition market estimates and forecasts by sales channel, 2018-2030 (USD Million)
Table 77 Saudi Arabia oral clinical nutrition market estimates and forecasts, by stage, 2018-2030 (USD Million)
Table 78 Saudi Arabia oral clinical nutrition market estimates and forecasts, by indication, 2018-2030 (USD Million)
Table 79 Saudi Arabia oral clinical nutrition market estimates and forecasts by sales channel, 2018-2030 (USD Million)
Table 80 UAE oral clinical nutrition market estimates and forecasts, by stage, 2018-2030 (USD Million)
Table 81 UAE oral clinical nutrition market estimates and forecasts, by indication, 2018-2030 (USD Million)
Table 82 UAE oral clinical nutrition market estimates and forecasts by sales channel, 2018-2030 (USD Million)
List of Figures
Figure 1 Oral Clinical Nutrition Market Segmentation
Figure 2 Information Procurement
Figure 3 Data Analysis Models
Figure 4 Market Formulation and Validation
Figure 5 Data Validating & Publishing
Figure 6 Market Snapshot
Figure 7 Segment Snapshot (1/2)
Figure 8 Segment Snapshot (2/2)
Figure 9 Competitive Landscape Snapshot
Figure 10 Oral Clinical Nutrition - Market Size and Growth Prospects (USD Million)
Figure 11 Oral Clinical Nutrition Market: Industry Value Chain Analysis
Figure 12 Oral Clinical Nutrition Market: Market Dynamics
Figure 13 Oral Clinical Nutrition Market: PORTER’s Analysis
Figure 14 Oral Clinical Nutrition Market: PESTEL Analysis
Figure 15 Oral Clinical Nutrition Market: Stage Movement Analysis, 2018-2030 (USD Million)
Figure 16 Oral Clinical Nutrition Market Share Analysis by Stage, 2024 & 2030
Figure 17 Adults Market Estimates & Forecasts, 2018-2030 (Revenue, USD Million)
Figure 18 Pediatrics Market Estimates & Forecasts, 2018-2030 (Revenue, USD Million)
Figure 19 Oral Clinical Nutrition Market: Indication Movement Analysis, 2018-2030 (USD Million)
Figure 20 Oral Clinical Nutrition Market Share Analysis by Indication , 2024 & 2030
Figure 21 Alzheimer’s Market Estimates & Forecasts, 2018-2030 (Revenue, USD Million)
Figure 22 Nutrition Deficiency Market Estimates & Forecasts, 2018-2030 (Revenue, USD Million)
Figure 23 Cancer Care Market Estimates & Forecasts, 2018-2030 (Revenue, USD Million)
Figure 24 Diabetes Market Estimates & Forecasts, 2018-2030 (Revenue, USD Million)
Figure 25 Chronic Kidney Diseases Market Estimates & Forecasts, 2018-2030 (Revenue, USD Million)
Figure 26 Orphan Diseases Market Estimates & Forecasts, 2018-2030 (Revenue, USD Million)
Figure 27 DysphagiaMarket Estimates & Forecasts, 2018-2030 (Revenue, USD Million)
Figure 28 Pain Management Market Estimates & Forecasts, 2018-2030 (Revenue, USD Million)
Figure 29 Malabsorption/GI Disorder/Diarrhea Market Estimates & Forecasts, 2018-2030 (Revenue, USD Million)
Figure 30 Others Market Estimates & Forecasts, 2018-2030 (Revenue, USD Million)
Figure 31 Oral Clinical Nutrition Market: Sales Channel Movement Analysis, 2018-2030 (USD Million)
Figure 32 Oral Clinical Nutrition Market Share Analysis by Sales Channel, 2024 & 2030
Figure 33 Online Sales Market Estimates & Forecasts, 2018-2030 (Revenue, USD Million)
Figure 34 Retail Sales Market Estimates & Forecasts, 2018-2030 (Revenue, USD Million)
Figure 35 Institutional Sales Market Estimates & Forecasts, 2018-2030 (Revenue, USD Million)
Figure 36 Oral Clinical Nutrition Market Revenue, by Region, 2024 & 2030 (USD Million)
Figure 37 Regional Marketplace: Key Takeaways
Figure 38 North America Oral Clinical Nutrition Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 39 U.S Oral Clinical Nutrition Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 40 Canada Oral Clinical Nutrition Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 41 Mexico Oral Clinical Nutrition Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 42 Europe Oral Clinical Nutrition Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 43 UK Oral Clinical Nutrition Market Estimates and Forecasts, 2018-2030,) (USD Million)
Figure 44 Germany Oral Clinical Nutrition Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 45 France Oral Clinical Nutrition Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 46 Italy Oral Clinical Nutrition Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 47 Spain Oral Clinical Nutrition Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 48 Sweden Oral Clinical Nutrition Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 49 Denmark Oral Clinical Nutrition Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 50 Norway Oral Clinical Nutrition Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 51 Asia Pacific Oral Clinical Nutrition Market Estimates and Forecast, 2018-2030 (USD Million)
Figure 52 Japan Oral Clinical Nutrition Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 53 China Oral Clinical Nutrition Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 54 India Oral Clinical Nutrition Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 55 Australia Oral Clinical Nutrition Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 56 Thailand Oral Clinical Nutrition Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 57 Latin America Oral Clinical Nutrition Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 58 Brazil Oral Clinical Nutrition Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 59 Argentina Oral Clinical Nutrition Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 60 MEA Oral Clinical Nutrition Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 61 Saudi Arabia Oral Clinical Nutrition Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 62 UAE Oral Clinical Nutrition Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 63 South Africa Oral Clinical Nutrition Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 64 Kuwait Oral Clinical Nutrition Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 65 Key Company Categorization
Figure 66 Company Market Positioning
Figure 67 Key Company Market Share Analysis, 2024
Figure 68 Strategic Framework

Companies Mentioned

The major companies featured in this Oral Clinical Nutrition market report include:
  • Fresenius Kabi AG
  • Abbott Laboratories
  • Pfizer Inc.
  • Bayer AG
  • Nestle S.A.
  • GlaxoSmithKline plc
  • Baxter International Inc.
  • Otsuka Holdings Co., Ltd.
  • Mead Johnson & Company, LLC
  • Danone (Nutricia)
  • B. Braun Melsungen AG.
  • Kate Farms, Inc.
  • Medline Industries, LP

Table Information